Synonyms:acemetacin, 53164-05-9, Rantudil, Emflex, Acemix, Acemetacinum, Acemetacina, Acemetacine, TVX 1322, indomethacin carboxymethyl ester, TVX 3322, K-708, 1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-, carboxymethyl ester, K 708, indometacin glycolic ester, indomethacin glycolic ester, NSC-757413, indometacin carboxymethyl ester, CHEMBL189171, DTXSID7022540, CHEBI:31162, 5V141XK28X, 2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid, 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid carboxymethyl ester, NCGC00016868-09, Aximeixin, Rheumibis, CAS-53164-05-9, 1-[p-Chlorobenzoyl]-5-methoxy-2-methylindole-3-acetic acid carboxymethyl ester, 1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid ester with glycolic acid, 2-(2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetoxy)acetic acid, DTXCID402540, Bay f 4975, 2-[2-[1-(4-chloro-2,3,5,6-tetradeuteriobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid, Acemetacine [INN-French], Acemetacinum [INN-Latin], Acemetacina [INN-Spanish], 1-(4-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic Acid Carboxymethyl Ester, SMR000058409, SR-01000000070, EINECS 258-403-4, BRN 0501672, Acemetacin [INN:BAN:JAN], Solart, UNII-5V141XK28X, Rantudil (TN), Prestwick_669, Acemetacin (Emflex), MFCD00151473, Spectrum_000428, ACEMETACIN [MI], ACEMETACIN [INN], ACEMETACIN [JAN], Prestwick0_000296, Prestwick1_000296, Prestwick2_000296, Prestwick3_000296, Spectrum2_001162, Spectrum3_001868, Spectrum4_000803, Spectrum5_001385, ((1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl)acetoxy)acetic acid, Acemetacin (JP17/INN), (1-(p-Chlorbenzoyl)-5-methoxy-2-methylindol-3-acetoxy)essigsaeure [German], 2-(2-(1-(p-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl)acetoxy)acetic acid, ACEMETACIN [MART.], ACEMETACIN [WHO-DD], Bay-f-4975, SCHEMBL23843, BSPBio_000232, BSPBio_003316, KBioGR_001285, KBioSS_000908, 5-22-05-00241 (Beilstein Handbook Reference), MLS000028440, MLS006010622, DivK1c_000490, SPECTRUM1500666, Acematacin (anti-inflammatory), SPBio_001143, SPBio_002451, Acemetacin, analytical standard, BPBio1_000256, HMS501I12, KBio1_000490, KBio2_000908, KBio2_003476, KBio2_006044, KBio3_002818, ACEMETACIN [EP MONOGRAPH], NINDS_000490, HMS1568L14, HMS1921A08, HMS2090E21, HMS2095L14, HMS2230G08, HMS3372K20, HMS3656E22, HMS3712L14, HMS3884P10, Pharmakon1600-01500666, BCP13127, HY-B0482, TVX-1322, Tox21_113473, (1-(p-Chlorbenzoyl)-5-methoxy-2-methylindol-3-acetoxy)essigsaeure, BDBM50336272, CCG-39550, NSC757413, s2602, AKOS015895194, Tox21_113473_1, AB03974, DB13783, NSC 757413, TV-1322, IDI1_000490, NCGC00016868-01, NCGC00016868-02, NCGC00016868-03, NCGC00016868-04, NCGC00016868-05, NCGC00016868-06, NCGC00016868-07, NCGC00016868-08, NCGC00016868-11, NCGC00016868-12, NCGC00022084-03, NCGC00022084-04, NCGC00022084-05, NCGC00022084-06, NCGC00022084-07, BS-16970, SBI-0051585.P002, DB-052263, A2452, AB00052149, FT-0630659, SW196824-3, D01582, D88520, AB00052149-15, AB00052149_16, AB00052149_17, from D:/data/P.Sapui/gsas_26052012/ps1.cif, A936725, EN300-24431224, Q2723146, SR-01000000070-2, SR-01000000070-3, BRD-K67563174-001-05-1, BRD-K67563174-001-09-3, Acemetacin, European Pharmacopoeia (EP) Reference Standard, [1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetoxyacetic Acid, [1-(p-Chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetoxy]-acetic acid, [({1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetyl)oxy]acetic acid, [1-(4-Chloro-benzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-acetic acid carboxymethyl ester, {2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetoxy}acetic acid, 2-({2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl}oxy)acetic acid, [({1-[(4-chlorophenyl)carbonyl]-2-methyl-5-(methyloxy)-1H-indol-3-yl}acetyl)oxy]acetic acid, [1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetoxyacetic Acid[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetoxyacetic Acid
Pubchem:PUBCHEM:1981
Id:e402862a-5312-59c5-be58-a4b2e79512f9
Description:nan
